Salute e Benessere

BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES

On September 15, 2025, the Company issued Debentures for an aggregate principal amount of $335,670 convertible into common shares in the capital of the Company ("Shares") at any time, at the option of the holders thereof, at the closing price of the Shares on the Canadian Securities Exchange (the "CSE") on the day notice of conversion is received by the Company, subject to the pricing requirements in the policies of the CSE. The Debentures bear interest at a rate of 10% per…
PR Newswire
28/10/2025

Alkermes plc Reports Third Quarter 2025 Financial Results

— Company Raises 2025 Financial Expectations — — Company Raises 2025 Financial Expectations — DUBLIN , Oct. 28, 2025 /PRNewswire/ --Alkermes plc(Nasdaq: ALKS) today reported financial results for the third quarter of 2025. "Alkermes delivered another successful quarter, achieving strong revenue growth and robust profitability, fueled by focused execution and underlying demand across our commercial portfolio. We ended the quarter in a strong financial position and have...
PR Newswire
28/10/2025

Amphista Therapeutics to showcase how its Targeted Glue™ technology is expanding…

Presentation will showcase the novel mechanisms of degradation of Amphista's Targeted Glues™, which recruit diverse E3 ligases, including DCAF16 and FBXO22, expanding the diversity and opportunity for TPD medicines.The Company’s Eclipsys® platform, founded on a multidisciplinary team employing leading-edge technologies, is delivering breakthrough accomplishments across it’s BRD9, SMARCA2 and TEAD programs.Cambridge, UK, 28 October, 2025– Amphista Therapeutics (“the Company” or...
Nasdaq GlobeNewswire
28/10/2025

AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical…

AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board Brings substantial expertise in development of first-in-class disease-modifying therapies in dementia across multiple novel modalitiesIncludes immunotherapies and small molecule drugs targeting intracellular proteinopathiesLeadership in groundbreaking early-stage clinical trials reinforces Company’s competencies Lausanne, Switzerland, October 28, 2025 --AC Immune SA (NASDAQ: ACIU), a...
Nasdaq GlobeNewswire
28/10/2025

Upgrade of guidance

ANNOUNCEMENT NO. 295 28 October 2025Upgrade of guidance ChemoMetec experiences an increased interest in its technology, not the least the XcytoMatic platform, and consequently expects a positive trend in revenue and profit particularly in the last part of the financial year 2025/26.Consequently, revenue in the financial year 2025/26 is now expected to be DKK 565-580 million against the most recently announced DKK 545-565 million, while EBITDA is expected to be in the range of...
Nasdaq GlobeNewswire
28/10/2025

Orion Group Interim Report January–September 2025

ORION CORPORATIONINTERIM REPORT 1–9/202528 OCTOBER 2025 at 12:00 EETOrion Group Interim Report January–September 2025July–September 2025 HighlightsNet sales totalled EUR 423.2 (July–September 2024: 471.3) million Operating profit was EUR 121.0 (202.0) millionNet sales and operating profit of the comparison period include EUR 130 million of major milestone paymentsBasic earnings per share were EUR 0.68 (1.14)Cash flow from operating activities per share was EUR 0.55 (0...
Nasdaq GlobeNewswire
28/10/2025

Clinical Trials Market Growing at 6.51% CAGR to 2030 Driven by Hybrid and…

Rising Adoption of Decentralized and Hybrid Trial Models Rising Adoption of Decentralized and Hybrid Trial Models Decentralized and hybrid trial models are transforming clinical research by reducing patient travel, improving retention, and expanding access through telehealth, local labs, and at-home monitoring. With growing acceptance among participants and clear regulatory guidance from the FDA, sponsors are focusing on technology readiness, data integrity, and cybersecurity as key...
PR Newswire
28/10/2025

WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic…

This partnership brings together WuXi AppTec's decades of experience as a trusted partner to the global biopharmaceutical industry with NEOM's commitment to fostering innovation and building a future-focused ecosystem. The MoU offers a compelling opportunity to extend WuXi AppTec's integrated capabilities into a market with ambitious national biotechnology goals. It also capitalizes on NEOM's visionary approach to sustainability, innovation, and talent development. This partnership brings...
PR Newswire
28/10/2025

LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS…

Phase 2b (LT3001-202, China): Efficacy and Safety OverviewThe China Phase 2b study met its primary endpoint of safety. No treatment-related symptomatic intracranial hemorrhage (sICH) was observed. Across all treatment groups, LT3001 demonstrated a consistent trend of functional improvement compared with placebo. At day 90, patients receiving LT3001 achieved a 7.3% higher rate of functional independence (mRS 0–2). Phase2b(LT3001-202,China ): Efficacy and Safety OverviewThe China Phase...
PR Newswire
28/10/2025

Xinhua Silk Road: Innovation, tradition deeply integrated on TCM trade fair in…

The fair also featured a one-stop match-making platform to help find partners for the TCM companies to put their latest innovative medicines and technologies into mass production. Ten cooperative agreements on TCM industrial projects covering medical equipment and new medicine development were signed on the fair. The fair also featured a one-stop match-making platform to help find partners for the TCM companies to put their latest innovative medicines and technologies into mass production...
PR Newswire
28/10/2025

ViCentra Strengthens Leadership Team to Accelerate Growth

"These are transformative additions to our leadership team," said Tom Arnold, Chief Executive Officer of ViCentra. "Karen brings an exceptional track record of scaling category-defining diabetes businesses across Europe through both direct sales as well as distributors. Jay adds deep strategic expertise in partnerships, reimbursement, and commercial execution. With their leadership, ViCentra is well-positioned to bring the Kaleido experience to more people living with…
PR Newswire
28/10/2025

Experience the Future of Clean: CCE 2026 Invites Global Professionals to…

Building on last year's success, CCE 2026 will feature the returning zones for Restroom Supplies, Smart Cleaning, and Environmental Sanitation, plus three new additions: Property Management, High-pressure Cleaning, and Laundry Products Zones. The Smart Cleaning Zone highlights one of the industry's fastest-growing sectors. The global commercial cleaning robot market is projected to reach USD 1.56 billion by 2031, growing at a 20.2% CAGR, driven by labor shortages and demand for smarter…
PR Newswire
28/10/2025

DJI's First All-in-One Robot Vacuum ROMO: Flagship Technology Flies into the…

Millimeter-Level Obstacle Sensing That Even Dodges Playing Cards Millimeter-Level Obstacle Sensing That Even Dodges Playing Cards ROMO features an advanced obstacle sensing system with high-performance dual fisheye vision sensors and wide-angle dual-transmitter solid-state LiDARs, leveraging technology derived from DJI's flagship drones. Coupled with machine learning this enables ROMO to recognize and avoid household obstacles such as 2mm thick charging cables or even playing cards...
PR Newswire
28/10/2025

Kanazawa University Research: Scanning nanoprobe microscope reveals the hidden…

Changes in nuclear mechanics are a hallmark of cancer and can indicate malignant transformation. Traditionally, nuclear elasticity has been studied using atomic force microscopy (AFM) probes pressing on the cell membrane or by aspirating isolated nuclei. Both methods suffer from limitations: they are influenced by surrounding cellular structures or fail to capture intact nuclear states. The new NE-AFM method developed by Takehiko Ichikawa and colleagues at Kanazawa University overcomes these…
PR Newswire
28/10/2025

Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through…

COPENHAGEN, Denmark, October 28, 2025– Bavarian Nordic announced today a donation of mpox vaccines to Africa CDC to support the response to the ongoing mpox outbreak in Africa.The donation of 110,000 doses of the vaccine has been allocated to Uganda in coordination with the key partners involved in the mpox Access and Allocation Mechanism (AAM), significantly increasing the availability of vaccines in the country, which has reported the second-highest number of cases of mpox in Africa in...
Nasdaq GlobeNewswire
28/10/2025

Novartis announces expiration of Tourmaline Bio tender offer 

Basel, October 28 2025 - Novartis today announced that its previously announced tender offer (the “offer”) by Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), to acquire all of the outstanding shares of common stock, par value $0.0001 per share (the “Shares”), of Tourmaline Bio, Inc., a Delaware corporation (“Tourmaline”), at a price of $48.00 per Share, in cash, without interest and subject to any applicable withholding,...
Nasdaq GlobeNewswire
28/10/2025

Navamedic ASA: Double digit growth in the 3rd quarter, 2025

The acquisition of the dne pharma business was completed in July, with a subsequent successful rights issue completed in October. The acquisition of the dne pharma business was completed in July, with a subsequent successful rights issue completed in October. "We are excited about the acquisition of the dne pharma business. The portfolio of products we have acquired fits well into the Navamedic setup and provides a new focus area with growth potential, Addiction, within our Rx portfolio...
PR Newswire
28/10/2025

Meiyume at Cosmopack Asia 2025: SEEDED -- Rooted in Intelligence, Connected…

At the heart of every innovation lies a seed—an idea ready to grow. SEEDED reflects how intelligence, ethical sourcing, inventive formulations, and sustainable packaging are interconnected at Meiyume, creating an ecosystem where innovation evolves into successful global products for clients and partners. At the heart of every innovation lies a seed—an idea ready to grow. SEEDED reflects how intelligence, ethical sourcing, inventive formulations, and sustainable packaging are interconnected at...
PR Newswire
28/10/2025

Novartis delivers solid sales and core operating income growth with strong…

Ad hoc announcement pursuant to Art. 53 LR Q3 net sales grew +7% (cc 1, +8% USD) and core operating income 1grew +7% (cc, +6% USD)Sales growth was driven by continued strong execution on priority brands includingKisqali(+68% cc),Kesimpta(+44% cc),Pluvicto(+45% cc) andScemblix(+95% cc)Core operating income margin 1was stable (cc) at 39.3% despite increasing generic impact Q3 operating income grew +27% (cc, +24% USD); net income rose +25% (cc, +23%…
Nasdaq GlobeNewswire
28/10/2025

Press release: Sanofi successfully prices USD 3 billion of bond issue

Sanofi successfully prices USD 3billion of bond issue Paris, France – October 28, 2025 -Sanofi announces that it has successfully priced its offering of $3 billion of notes across 5 tranches: $400 million fixed rate notes, due November 2027, bearing interest at a rate of 3.75%. $500 million floating rate notes, due November 2027, bearing interest at compounded SOFR plus 0.46%. $400 million fixed rate notes, due November 2028, bearing interest at a rate of 3.80%. $500 million...
Nasdaq GlobeNewswire
28/10/2025

Positive phase III results for Roche’s Gazyva/Gazyvaro in children and young…

Gazyva/Gazyvaro versus mycophenolate mofetil shows significantly more children and young adults achieved sustained complete remission at week 52 If approved, Gazyva/Gazyvaro could help children and young adults sustain remission, potentially with a reduced need for steroids to manage their disease 1 INShore is the first global phase III study of a targeted therapy in this chronic kidney disease commonly diagnosed in early childhoodBasel, 28 October 2025 - Roche (SIX: RO, ROG;...
Nasdaq GlobeNewswire
28/10/2025

138th Canton Fair Exhibitors Respond to Global Consumer Trends with Sustainable…

At this session, several exhibitors are introducing new eco-friendly household solutions. One exhibitor presented a biodegradable tableware collection made from agricultural byproducts such as sugarcane pulp, which naturally decomposes by more than 90% within a month. The series has earned multiple patents and international certifications for food safety. Another exhibitor focused on modular home storage systems crafted from recycled polypropylene (PP), designed with detachable components that…
PR Newswire
28/10/2025

Onward Therapeutics Exercises Exclusive Option and Signs Worldwide License…

The program, designated OT-S00X by Onward Therapeutics, is an innovative onco-metabolism project aimed at expanding therapeutic possibilities in cancer treatment. Proof-of-principle studies have demonstrated strong preclinical efficacy, and promising candidates from two distinct chemical series have already been identified, and compounds with improved physico-chemical properties will be generated through artificial intelligence approaches. The program, designated OT-S00X by Onward...
PR Newswire
28/10/2025

Basal Cell Nevus Syndrome Market Growth Accelerates with Novel Therapies and…

Basal Cell Nevus Syndrome Market Summary Basal Cell Nevus Syndrome Market Summary Discover the basal cell nevus syndrome new treatment @New Treatments for Basal Cell Nevus Syndrome Key Factors Driving the Growth of the Basal Cell Nevus Syndrome Market Rising BCNS Prevalence and Awareness BCNS, also known as Gorlin Syndrome, is a rare genetic disorder characterized by multiple basal cell carcinomas and other abnormalities. The estimated prevalence inEuropevaries...
PR Newswire
27/10/2025
Altri  Comunicati